Association
Related entities
Findings (50)
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineBronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an
Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64
None
declineSevere intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo
Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64